We are live on ! Find out more
LCM

Legato Capital Management Portfolio holdings

AUM $1.21B
1-Year Est. Return 82.36%
This Fund
S&P 500
This Quarter Est. Return
+20.32%
1 Year Est. Return
+82.36%
3 Year Est. Return
+243.02%
5 Year Est. Return
+342.37%
10 Year Est. Return
+764.01%
AUM
$839M
AUM Growth
+$97.1M
Cap. Flow
-$4M
Cap. Flow %
-0.48%
Top 10 Hldgs %
11.75%
Holding
636
New
73
Increased
165
Reduced
183
Closed
74

Top Sells

Rank Stock Value
1
AGX icon
Argan
AGX
+$3.01M
2
STGW icon
Stagwell
STGW
+$2.84M
3
PLMR icon
Palomar
PLMR
+$2.46M
4
NUTX
Nutex Health
NUTX
+$2.09M
5
SR icon
Spire
SR
+$1.93M

Sector Composition

Rank Sector Weight
1 Technology 27.91%
2 Industrials 19.42%
3 Healthcare 15.62%
4 Financials 10.98%
5 Consumer Discretionary 10.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HDSN
526
Hudson Technologies
HDSN
$235M
$150K 0.02%
18,479
-932
-5% -$6.39K
AHCO icon
527
AdaptHealth
AHCO
$759M
$138K 0.02%
14,625
-738
-5% -$6.51K
NEXN
528
Nexxen International
NEXN
$607M
$136K 0.02%
+13,089
New +$133K
AVAH icon
529
Aveanna Healthcare
AVAH
$2.07B
$129K 0.02%
24,622
+6,479
+36% +$32.9K
MYO icon
530
Myomo
MYO
$56.2M
$127K 0.02%
58,932
-174,609
-75% -$633K
IMXI icon
531
International Money Express
IMXI
$367M
$123K 0.01%
12,182
-615
-5% -$7.02K
WNEB icon
532
Western New England Bancorp
WNEB
$275M
$120K 0.01%
13,027
-3,857
-23% -$35K
EOLS icon
533
Evolus
EOLS
$501M
$97.5K 0.01%
10,583
-52,846
-83% -$541K
NPKI
534
NPK International
NPKI
$1.14B
$95.7K 0.01%
11,243
-564
-5% -$4.13K
MDXG icon
535
MiMedx Group
MDXG
$633M
$89.4K 0.01%
14,633
+1,409
+11% +$9.37K
BVS icon
536
Bioventus
BVS
$1.19B
$79.7K 0.01%
+12,037
New +$85.4K
INDI icon
537
indie Semiconductor
INDI
$854M
$76K 0.01%
21,356
-347
-2% -$873
UROY
538
Uranium Royalty Corp
UROY
$1.58B
$68.3K 0.01%
27,326
+13,635
+100% +$27.6K
NCMI icon
539
National CineMedia
NCMI
$378M
$67.8K 0.01%
13,996
-702
-5% -$3.81K
OSS icon
540
One Stop Systems
OSS
$330M
$60.8K 0.01%
17,132
-852
-5% -$2.38K
LPTH icon
541
Lightpath Technologies
LPTH
$820M
$56.9K 0.01%
18,483
-921
-5% -$2.29K
PACK icon
542
Ranpak Holdings
PACK
$473M
$56.6K 0.01%
15,856
+423
+3% +$1.57K
SCPH
543
DELISTED
scPharmaceuticals
SCPH
$55.5K 0.01%
14,568
-707
-5% -$2.19K
DAIO icon
544
Data I/O
DAIO
$30.6M
$54.4K 0.01%
17,550
+6,874
+64% +$17.3K
RPID icon
545
Rapid Micro Biosystems
RPID
$86.2M
$50.7K 0.01%
14,684
-731
-5% -$2.12K
OABI icon
546
OmniAb
OABI
$447M
$49K 0.01%
28,189
-530
-2% -$887
CPSH icon
547
CPS Technologies
CPSH
$86.1M
$48.3K 0.01%
+17,426
New +$37.2K
FTEK icon
548
Fuel Tech
FTEK
$43.7M
$45.8K 0.01%
18,165
-12,160
-40% -$17.3K
TEAD
549
Teads Holding Co
TEAD
$67.7M
$45.4K 0.01%
18,297
+1,406
+8% +$4.25K
KRMD icon
550
KORU Medical Systems
KRMD
$164M
$44.9K 0.01%
12,548
-615
-5% -$1.75K

Similar funds

Legato Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Legato Capital Management held 636 positions worth $839M, up 13% from $742M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Legato Capital Management's Q2 2025 filing shows 73 new, 165 increased, 183 reduced and 74 closed positions. Its largest new stake was Steven Madden: 76,021 shares worth $1.82M. The largest sale was Argan, an estimated $3.01M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Industrials and Healthcare.

  • Legato Capital Management's largest Q2 2025 buy was Steven Madden: 76,021 shares worth $1.82M.
  • Legato Capital Management added most to TripAdvisor in Q2 2025, an estimated $2.54M increase.
  • Legato Capital Management's biggest Q2 2025 reduction was Argan, cutting an estimated $3.01M.
  • Legato Capital Management fully exited Stagwell in Q2 2025, selling an estimated $2.84M.
  • Legato Capital Management's ten largest holdings make up 12% of its $839M portfolio in Q2 2025.
  • Legato Capital Management opened 73 new positions and closed 74 in Q2 2025.
  • Legato Capital Management's portfolio value rose 13% quarter-over-quarter to $839M.

Based on Legato Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.